CompletedNot Applicable

Sugammadex v.s. Neostigmine/Glycopyrrolate

Taiwan124 participantsStarted 2024-05-01

Plain-language summary

The aim of study is to clarify the role of sugammadex in ENT surgery patients with a prior history of postoperative urinary retention, benign prostatic hypertrophy, or a history of prostate cancer, to prevent postoperative urinary retention. The main question it aims to answer are: * Anticholinergic agent interferes the postoperative urination * Sugammadex does not interfere postoperative urination Sugammadex can be recommended for these patients with high risk in postoperative urinary retention in the future.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ENT surgery patients whose surgery is expected to take less than three hours and no planned Foley catheter * high risk of postoperative urinary retention, including * prior history of postoperative urinary retention * benign prostatic hypertrophy * history of prostate cancer Exclusion Criteria: * refusal or inability to provide informed consent * age younger than 18 years * American Society of Anesthesiologists class more than III * pregnancy * impaired renal function (creatinine clearance \< 30 mL/min) * allergy to a study drug

What they're measuring

postoperative urinary retention

Timeframe: up to 48 hours

Trial details

NCT IDNCT06398899

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-12

View on ClinicalTrials.gov More Head and Neck Surgery trials